Chris Sereduk

Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing

Mitchell Stark, Susan L. Woods, Michael G. Gartside et al. · Nature Genetics · 2011 · 195 citations

Medicine, Genetics, Oncology +16

Identification of Molecular Vulnerabilities in Human Multiple Myeloma Cells by RNA Interference Lethality Screening of the Druggable Genome

Rodger E. Tiedemann, Yuan Xao Zhu, Jessica Schmidt et al. · Cancer Research · 2011 · 129 citations · Full text

Life Sciences, Genetics, Molecular Biology +14

RNAi screen of the druggable genome identifies modulators of proteasome inhibitor sensitivity in myeloma including CDK5

Yuan Xiao Zhu, Rodger E. Tiedemann, Chang-Xin Shi et al. · Blood · 2011 · 105 citations · Full text

Medicine, Molecular Biology, Oncology +11

Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase Inhibition

Jessica D. Lang, William P.D. Hendricks, Krystal A. Orlando et al. · Clinical Cancer Research · 2018 · 70 citations · Full text

Medicine, Oncology, Pharmacology +16

PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic Targets

Marzia Scortegagna, Eric Lau, Tongwu Zhang et al. · Cancer Research · 2015 · 60 citations · Full text

Medicine, Cancer Biology, Oncology +17